![](/img/cover-not-exists.png)
Nonalcoholic fatty liver disease (NAFLD) – Is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis?
Orlic, L., Mikolasevic, I., Lukenda, V., Racki, S., Stimac, D., Milic, S.Volume:
83
Language:
english
Journal:
Medical Hypotheses
DOI:
10.1016/j.mehy.2014.10.012
Date:
December, 2014
File:
PDF, 230 KB
english, 2014